| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 540,772 | 522,839 | 526,944 | 580,924 | | Cost of Revenue | 240,747 | 232,413 | 231,984 | 252,442 | | | Gross Profit | 300,025 | 290,426 | 294,960 | 328,482 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 166,886 | 162,919 | 160,406 | 157,844 | | Non Recurring | 104,301 | 25,428 |
-
| 9,408 | | Others | 34,381 | 32,793 | 33,689 | 34,660 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,543) | 69,286 | 100,865 | 126,570 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,228) | 4,999 | 5,902 | (11,485) | | Earnings Before Interest And Taxes | (13,771) | 74,285 | 106,767 | 115,085 | | Interest Expense | 8,960 | 9,055 | 9,476 | 11,836 | | Income Before Tax | (22,731) | 65,230 | 97,291 | 103,249 | | Income Tax Expense | (13,474) | 1,518 | (37,165) | 4,781 | | Minority Interest | (1,994) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,251) | 63,712 | 134,456 | 98,468 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,251) | 63,712 | 134,456 | 98,468 | | Preferred Stock And Other Adjustments | 1,953 | (829) | (1,124) |
-
| | | Net Income Applicable To Common Shares | ($9,298) | $62,883 | $133,332 | $98,468 |
|
0.29% Nasdaq 
0.06 (0.28%) 
Income Statement
